NO151411C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater

Info

Publication number: NO151411C
Authority: NO; Norway
Prior art keywords: alkylenaminopropane; aryloxy; hydroxy; derivatives; preparation
Prior art date: 1976-10-05

Application number

NO773384A

Other languages

English (en)

Other versions

NO151411B (no

NO773384L (no

Inventor

Herbert Koeppe

Anton Mentrup

Ernst-Otto Renth

Kurt Schromm

Wolfgang Hoefke

Gojko Muacevic

Original Assignee

Boehringer Sohn Ingelheim

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-10-05

Filing date

1977-10-04

Publication date

1985-04-10

1977-10-04 Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim

1978-04-06 Publication of NO773384L publication Critical patent/NO773384L/no

1984-12-27 Publication of NO151411B publication Critical patent/NO151411B/no

1985-04-10 Publication of NO151411C publication Critical patent/NO151411C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Quinoline Compounds (AREA)

NO773384A 1976-10-05 1977-10-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater NO151411C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19762644833 DE2644833A1 (de)	1976-10-05	1976-10-05	Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (3)

Publication Number	Publication Date
NO773384L NO773384L (no)	1978-04-06
NO151411B NO151411B (no)	1984-12-27
NO151411C true NO151411C (no)	1985-04-10

Family

ID=5989679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO773384A NO151411C (no)	1976-10-05	1977-10-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater

Country Status (33)

Country	Link
US (7)	US4256756A (no)
JP (1)	JPS5368775A (no)
AT (15)	AT361908B (no)
AU (1)	AU514600B2 (no)
BE (1)	BE859415A (no)
BG (1)	BG33153A3 (no)
CA (4)	CA1101859A (no)
CS (1)	CS197304B2 (no)
DD (5)	DD148052A5 (no)
DE (1)	DE2644833A1 (no)
DK (1)	DK439077A (no)
ES (16)	ES462868A1 (no)
FI (1)	FI69066C (no)
FR (1)	FR2394534A1 (no)
GB (3)	GB1592975A (no)
GR (1)	GR64229B (no)
HK (1)	HK19385A (no)
HU (1)	HU177173B (no)
IE (3)	IE46158B1 (no)
IL (1)	IL53043A (no)
LU (1)	LU78240A1 (no)
MY (1)	MY8500909A (no)
NL (1)	NL7710840A (no)
NO (1)	NO151411C (no)
NZ (1)	NZ185356A (no)
PH (4)	PH15763A (no)
PL (1)	PL113879B1 (no)
PT (1)	PT67107B (no)
SE (1)	SE442400B (no)
SG (1)	SG70884G (no)
SU (1)	SU665801A3 (no)
YU (1)	YU40484B (no)
ZA (1)	ZA775905B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4404380A (en) *	1977-02-14	1983-09-13	Mead Johnson & Company	Triazolopyrimidines
DE2833140A1 (de) *	1978-07-28	1980-02-07	Boehringer Sohn Ingelheim	Neue n-substituierte heterocyclen
PT71175A (fr) *	1979-05-04	1980-05-01	Continental Pharma	Procede pour preparer derives de benzimidazoles
US4656168A (en) *	1980-12-23	1987-04-07	Merck & Co., Inc.	(3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4349673A (en) *	1980-12-23	1982-09-14	Merck & Co., Inc.	Benzoxazines
US4473501A (en) *	1981-05-04	1984-09-25	G. D. Searle & Co.	Dihydro azino isoquinolines
US4379508A (en) *	1981-10-14	1983-04-12	Nestier Corporation	Nesting tray with stacking keyed interlock
IT1193608B (it) *	1983-01-21	1988-07-21	Pierrel Spa	Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) *	1983-07-09	1985-01-17	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) *	1984-08-03	1984-09-05	Beecham Group Plc	Compounds
DE3807922A1 (de) *	1988-03-10	1989-09-21	Boehringer Mannheim Gmbh	Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (no) *	1990-04-13	1993-04-01	Yamanouchi Pharma Co Ltd
US6860524B1 (en)	1993-05-14	2005-03-01	William W. Rowley	Polyolefin connectors
US6557907B2 (en)	1993-05-14	2003-05-06	William W. Rowley	Polyethylene connectors
US6372712B1 (en)	1998-05-22	2002-04-16	The Board Of Trustees Of The Leland Stanford Jr. University	Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
JP4202250B2 (ja)	2001-07-25	2008-12-24	バイオマリンファーマシューティカルインコーポレイテッド	血液脳関門輸送を調節するための組成物および方法
US6848719B2 (en)	2001-09-06	2005-02-01	William W. Rowley	Bendable polymer-lined water heater connector
MY143244A (en)	2002-11-26	2011-04-15	Smithkline Beecham Corp	Calcilytic compounds
CA2511496A1 (en) *	2002-12-23	2004-07-15	Artesian Therapeutics, Inc.	Cardiotonic compounds with inhibitory activity against .beta.-adrenergic receptors and phosphodiesterase
DE102004045648A1 (de) *	2004-09-21	2006-03-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080255134A1 (en) *	2004-11-30	2008-10-16	Artesian Therapeutics, Inc.	Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
EP3827747A1 (en)	2005-04-28	2021-06-02	Otsuka Pharmaceutical Co., Ltd.	Pharma-informatics system
CA2663377A1 (en)	2006-09-18	2008-03-27	Raptor Pharmaceutical Inc.	Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009070736A1 (en) *	2007-11-29	2009-06-04	Inolex Investment Corporation	Preservatives for cosmetic, toiletry and pharmaceutical compositions
EP2398500B1 (en)	2009-02-20	2019-03-13	2-BBB Medicines B.V.	Glutathione-based drug delivery system
IL255113B (en)	2009-05-06	2022-09-01	Laboratory Skin Care Inc	Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL284529A (no) *	1961-10-24
GB1066613A (en) *	1965-03-03	1967-04-26	Ici Ltd	Naphthalene derivatives
NL145842B (nl) *	1969-11-28	1975-05-15	Teikoku Hormone Mfg Co Ltd	Werkwijze voor het bereiden van 1-aryloxy 3-amino 2-propanolderivaten.
ZA71932B (en) *	1970-02-27	1971-10-27	Ici Ltd	Organic compounds
BE787103A (fr) *	1971-08-04	1973-02-02	Pfizer	Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3894030A (en) *	1973-01-04	1975-07-08	Janssen Pharmaceutica Nv	1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3818017A (en) *	1973-01-04	1974-06-18	Janssen Pharmaceutica Nv	1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) *	1973-07-18	1976-11-24	Ici Ltd	Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) *	1975-01-27	1976-07-29	Boehringer Sohn Ingelheim	Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) *	1975-04-09	1978-03-28	Abbott Laboratories	5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (no) *	1976-01-08	1981-07-31	Ciba Geigy Ag
DE2609645A1 (de) *	1976-03-09	1977-09-15	Boehringer Sohn Ingelheim	Aminoalkylheterocyclen

1976
- 1976-10-05 DE DE19762644833 patent/DE2644833A1/de not_active Withdrawn
1977
- 1977-09-22 AT AT679377A patent/AT361908B/de not_active IP Right Cessation
- 1977-09-26 FI FI772823A patent/FI69066C/fi not_active IP Right Cessation
- 1977-10-03 DD DD77217961A patent/DD148052A5/de unknown
- 1977-10-03 DD DD77201314A patent/DD134642A5/xx unknown
- 1977-10-03 LU LU7778240A patent/LU78240A1/xx unknown
- 1977-10-03 DD DD77212491A patent/DD143074A5/de unknown
- 1977-10-03 BG BG037483A patent/BG33153A3/xx unknown
- 1977-10-03 DD DD77217956A patent/DD148051A5/de unknown
- 1977-10-03 IL IL53043A patent/IL53043A/xx unknown
- 1977-10-03 HU HU77BO1685A patent/HU177173B/hu unknown
- 1977-10-03 DD DD77217954A patent/DD148050A5/de unknown
- 1977-10-03 PT PT67107A patent/PT67107B/pt unknown
- 1977-10-04 ZA ZA00775905A patent/ZA775905B/xx unknown
- 1977-10-04 ES ES462868A patent/ES462868A1/es not_active Expired
- 1977-10-04 CA CA288,058A patent/CA1101859A/en not_active Expired
- 1977-10-04 NL NL7710840A patent/NL7710840A/xx not_active Application Discontinuation
- 1977-10-04 DK DK439077A patent/DK439077A/da not_active Application Discontinuation
- 1977-10-04 GB GB41251/77A patent/GB1592975A/en not_active Expired
- 1977-10-04 PL PL1977201286A patent/PL113879B1/pl unknown
- 1977-10-04 GB GB41738/79A patent/GB1592977A/en not_active Expired
- 1977-10-04 NO NO773384A patent/NO151411C/no unknown
- 1977-10-04 GR GR54491A patent/GR64229B/el unknown
- 1977-10-04 SU SU772527654A patent/SU665801A3/ru active
- 1977-10-04 JP JP11938777A patent/JPS5368775A/ja active Granted
- 1977-10-04 YU YU2369/77A patent/YU40484B/xx unknown
- 1977-10-04 GB GB41737/79A patent/GB1592976A/en not_active Expired
- 1977-10-04 AU AU29333/77A patent/AU514600B2/en not_active Expired
- 1977-10-05 NZ NZ185356A patent/NZ185356A/xx unknown
- 1977-10-05 FR FR7729973A patent/FR2394534A1/fr active Granted
- 1977-10-05 IE IE2038/77A patent/IE46158B1/en unknown
- 1977-10-05 IE IE2410/82A patent/IE46160B1/en unknown
- 1977-10-05 CS CS776449A patent/CS197304B2/cs unknown
- 1977-10-05 IE IE2409/82A patent/IE46159B1/en unknown
- 1977-10-05 SE SE7711168A patent/SE442400B/xx not_active IP Right Cessation
- 1977-10-05 BE BE181490A patent/BE859415A/xx not_active IP Right Cessation
1978
- 1978-07-17 ES ES471802A patent/ES471802A1/es not_active Expired
- 1978-07-17 ES ES471799A patent/ES471799A1/es not_active Expired
- 1978-07-17 ES ES471808A patent/ES471808A1/es not_active Expired
- 1978-07-17 ES ES471803A patent/ES471803A1/es not_active Expired
- 1978-07-17 ES ES471807A patent/ES471807A1/es not_active Expired
- 1978-07-17 ES ES471795A patent/ES471795A1/es not_active Expired
- 1978-07-17 ES ES471806A patent/ES471806A1/es not_active Expired
- 1978-07-17 ES ES471801A patent/ES471801A1/es not_active Expired
- 1978-07-17 ES ES471797A patent/ES471797A1/es not_active Expired
- 1978-07-17 ES ES471800A patent/ES471800A1/es not_active Expired
- 1978-07-17 ES ES471804A patent/ES471804A1/es not_active Expired
- 1978-07-17 ES ES471798A patent/ES471798A1/es not_active Expired
- 1978-07-17 ES ES471794A patent/ES471794A1/es not_active Expired
- 1978-07-17 ES ES471796A patent/ES471796A1/es not_active Expired
- 1978-07-17 ES ES471805A patent/ES471805A1/es not_active Expired
1979
- 1979-01-17 US US06/004,279 patent/US4256756A/en not_active Expired - Lifetime
- 1979-01-17 US US06/004,280 patent/US4212877A/en not_active Expired - Lifetime
- 1979-08-30 PH PH22979A patent/PH15763A/en unknown
- 1979-12-14 US US06/103,724 patent/US4255430A/en not_active Expired - Lifetime
1980
- 1980-01-16 US US06/112,640 patent/US4296117A/en not_active Expired - Lifetime
- 1980-02-04 AT AT57380A patent/AT362363B/de not_active IP Right Cessation
- 1980-02-04 AT AT56980A patent/AT361913B/de not_active IP Right Cessation
- 1980-02-04 AT AT57180A patent/AT361915B/de not_active IP Right Cessation
- 1980-02-04 AT AT57480A patent/AT362364B/de not_active IP Right Cessation
- 1980-02-04 AT AT56780A patent/AT361911B/de not_active IP Right Cessation
- 1980-02-04 AT AT57280A patent/AT362362B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057580A patent/AT363079B/de not_active IP Right Cessation
- 1980-02-04 AT AT57880A patent/AT362365B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057980A patent/AT363082B/de not_active IP Right Cessation
- 1980-02-04 AT AT57080A patent/AT361914B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057680A patent/AT363080B/de not_active IP Right Cessation
- 1980-02-04 AT AT56880A patent/AT361912B/de not_active IP Right Cessation
- 1980-02-04 AT AT0058080A patent/AT364828B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057780A patent/AT363081B/de not_active IP Right Cessation
- 1980-10-09 PH PH24696A patent/PH16053A/en unknown
- 1980-10-09 US US06/195,650 patent/US4381309A/en not_active Expired - Lifetime
1981
- 1981-02-05 CA CA370,239A patent/CA1127643A/en not_active Expired
- 1981-02-05 CA CA370,237A patent/CA1126271A/en not_active Expired
- 1981-02-05 CA CA370,238A patent/CA1125751A/en not_active Expired
- 1981-04-20 US US06/255,751 patent/US4343800A/en not_active Expired - Fee Related
1982
- 1982-05-10 PH PH27256A patent/PH18363A/en unknown
- 1982-11-11 PH PH28126A patent/PH19028A/en unknown
1984
- 1984-07-25 US US06/634,446 patent/US4604468A/en not_active Expired - Fee Related
- 1984-10-05 SG SG708/84A patent/SG70884G/en unknown
1985
- 1985-03-14 HK HK193/85A patent/HK19385A/xx unknown
- 1985-12-30 MY MY909/85A patent/MY8500909A/xx unknown

Also Published As

Publication number	Publication date
US4296117A (en)	1981-10-20
BG33153A3 (en)	1982-12-15
ATA57380A (de)	1980-10-15
ES471804A1 (es)	1979-02-01
IL53043A (en)	1982-01-31
AT361913B (de)	1981-04-10
US4256756A (en)	1981-03-17
GB1592976A (en)	1981-07-15
GB1592977A (en)	1981-07-15
AU514600B2 (en)	1981-02-19
ES471802A1 (es)	1979-02-01
ES471796A1 (es)	1979-02-01
ES471806A1 (es)	1979-02-01
ATA57180A (de)	1980-09-15
ATA57080A (de)	1980-09-15
ES471803A1 (es)	1979-02-01
AT362365B (de)	1981-05-11
ATA57480A (de)	1980-10-15
ATA57880A (de)	1980-10-15
IE46158L (en)	1978-04-05
FR2394534A1 (fr)	1979-01-12
IL53043A0 (en)	1977-12-30
AT361911B (de)	1981-04-10
JPS6210988B2 (no)	1987-03-10
IE46158B1 (en)	1983-03-09
ES471794A1 (es)	1979-02-01
YU40484B (en)	1986-02-28
HK19385A (en)	1985-03-22
SE7711168L (sv)	1978-05-18
YU236977A (en)	1983-01-21
PH15763A (en)	1983-03-22
CA1101859A (en)	1981-05-26
AT362364B (de)	1981-05-11
NZ185356A (en)	1981-05-01
US4604468A (en)	1986-08-05
ZA775905B (en)	1979-06-27
DD148050A5 (de)	1981-05-06
BE859415A (fr)	1978-04-05
ES471808A1 (es)	1979-02-01
IE822410L (en)	1978-04-05
NL7710840A (nl)	1978-04-07
FI69066B (fi)	1985-08-30
ES471798A1 (es)	1979-02-01
ATA56880A (de)	1980-09-15
DD148051A5 (de)	1981-05-06
PT67107B (de)	1980-04-07
ES471797A1 (es)	1979-02-01
FR2394534B1 (no)	1982-04-30
AT362363B (de)	1981-05-11
ES471805A1 (es)	1979-02-01
AT361912B (de)	1981-04-10
IE46160B1 (en)	1983-03-09
ES471801A1 (es)	1979-02-01
HU177173B (en)	1981-08-28
IE822409L (en)	1978-04-05
AT361908B (de)	1981-04-10
ATA57680A (de)	1980-12-15
FI69066C (fi)	1985-12-10
CA1127643A (en)	1982-07-13
DK439077A (da)	1978-04-06
CA1125751A (en)	1982-06-15
US4212877A (en)	1980-07-15
ES462868A1 (es)	1978-12-16
NO151411B (no)	1984-12-27
AT363080B (de)	1981-07-10
US4381309A (en)	1983-04-26
SG70884G (en)	1985-04-04
NO773384L (no)	1978-04-06
DD148052A5 (de)	1981-05-06
AT363079B (de)	1981-07-10
CA1126271A (en)	1982-06-22
PH18363A (en)	1985-06-13
PL113879B1 (en)	1981-01-31
ATA679377A (de)	1980-09-15
ATA58080A (de)	1981-04-15
PH19028A (en)	1985-12-06
GR64229B (en)	1980-02-14
FI772823A (fi)	1978-04-06
ATA57980A (de)	1980-12-15
ATA57580A (de)	1980-12-15
SE442400B (sv)	1985-12-23
AT363081B (de)	1981-07-10
AU2933377A (en)	1979-04-12
IE46159B1 (en)	1983-03-09
SU665801A3 (ru)	1979-05-30
AT362362B (de)	1981-05-11
AT363082B (de)	1981-07-10
DE2644833A1 (de)	1978-04-20
ATA56980A (de)	1980-09-15
AT361914B (de)	1981-04-10
DD134642A5 (de)	1979-03-14
US4255430A (en)	1981-03-10
PT67107A (de)	1977-11-01
ES471800A1 (es)	1979-02-01
ES471795A1 (es)	1979-02-01
ATA56780A (de)	1980-09-15
AT364828B (de)	1981-11-25
DD143074A5 (de)	1980-07-30
PH16053A (en)	1983-06-09
JPS5368775A (en)	1978-06-19
AT361915B (de)	1981-04-10
ES471799A1 (es)	1979-02-01
US4343800A (en)	1982-08-10
ATA57780A (de)	1980-12-15
MY8500909A (en)	1985-12-31
LU78240A1 (no)	1979-02-02
ES471807A1 (es)	1979-02-01
PL201286A1 (pl)	1978-12-04
GB1592975A (en)	1981-07-15
ATA57280A (de)	1980-10-15
CS197304B2 (en)	1980-04-30

Publication	Publication Date	Title
NO147243C (no)	1983-03-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151321C (no)	1985-03-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no)	1985-04-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151411C (no)	1985-04-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO149586C (no)	1984-05-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO148453C (no)	1983-10-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO800881L (no)	1980-09-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO144848C (no)	1981-11-25	Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO148777C (no)	1984-01-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO149065C (no)	1984-02-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO150044C (no)	1984-08-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO145842C (no)	1982-06-09	Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO145951C (no)	1982-06-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater
NO149313C (no)	1984-03-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no)	1984-02-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148291C (no)	1983-09-14	Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148454C (no)	1983-10-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148488C (no)	1983-10-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO145163C (no)	1982-01-27	Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO143903C (no)	1981-05-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO152172C (no)	1985-08-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO146710C (no)	1982-11-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater
NO152556C (no)	1985-10-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO146600C (no)	1982-11-03	Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
NO147273C (no)	1983-03-09	Analogifremgangsmaate til fremstilling av terapeutisk aktive cykloheksadien-derivater